Abstract
There is increasing evidence of the potential therapeutic value of the psychedelic brew ayahuasca for disorders like depression, PTSD, and anxiety. While the focus has been on ayahuasca’s capacity to reduce symptoms of these disorders, including enhancing mood state and well-being, little attention has been paid to the (higher-order) cognitive processes that may be enhanced or that may play a role in this. Examples of such processes include flexible (creative) thinking, empathy, and emotion regulation, which are crucial for everyday interactions and cooperation, and have been found to be decreased in certain pathological populations. The aim of the present chapter is to review the acute and long-term effects of ayahuasca on (higher-order) cognitive processes, such as flexible (creative) thinking, empathy, and emotion regulation, and look for the link between these cognitive effects and subjective mood state and well-being.
Findings show that, although objective evidence is limited due to a scarcity of studies, previous studies with ayahuasca and similar psychedelics, like psilocybin and LSD, support the notion that ayahuasca can enhance previously mentioned higher-order cognitive processes. Importantly, evidence is given to suggest that this enhancement outlasts the acute stage, thus potentially persisting over time. Unfortunately, no study assessed the relationship between these cognitive effects and mood and well-being.
It is concluded that, while these findings partially explain why ayahuasca has therapeutic utility in the treatment of certain psychopathologies, future clinical research into the therapeutic effects of ayahuasca could assess the relationship between the effect on (higher-order) cognitive and emotional processes and mood and well-being and test the role both play in symptom alleviation in the pathological population in the short and longer term.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Aldao, A., Nolen-Hoeksema, S., & Schweizer, S. (2010). Emotion-regulation strategies across psychopathology: A meta-analytic review. Clinical Psychology Review, 30(2), 217–237. https://doi.org/10.1016/j.cpr.2009.11.004.
Amabile, T. M. (1982). Social psychology of creativity: A consensual assessment technique. Journal of Personality and Social Psychology, 43(5), 997–1013. https://doi.org/10.1037/0022-3514.43.5.997.
Baas, M., De Dreu, C. K., & Nijstad, B. A. (2008). A meta-analysis of 25 years of mood-creativity research: Hedonic tone, activation, or regulatory focus? Psychological Bulletin, 134(6), 779–806. https://doi.org/10.1037/a0012815.
Barbosa, P. C., Giglio, J. S., & Dalgalarrondo, P. (2005). Altered states of consciousness and short-term psychological after-effects induced by the first time ritual use of ayahuasca in an urban context in Brazil. Journal of Psychoactive Drugs, 37(2), 193–201. https://doi.org/10.1080/02791072.2005.10399801.
Barbosa, P. C., Strassman, R. J., da Silveira, D. X., Areco, K., Hoy, R., Pommy, J., Thoma, R., & Bogenschutz, M. (2016). Psychological and neuropsychological assessment of regular hoasca users. Comprehensive Psychiatry, 71, 95–105. https://doi.org/10.1016/j.comppsych.2016.09.003.
Baron-Cohen, S., Wheelwright, S., Hill, J., Raste, Y., & Plumb, I. (2001). The “Reading the Mind in the Eyes” test revised version: A study with normal adults, and adults with Asperger syndrome or high-functioning autism. Journal of Child Psychology and Psychiatry, 42(2), 241–251. https://doi.org/10.1111/1469-7610.00715.
Beketayev, K., & Runco, M. A. (2016). Scoring divergent thinking tests by computer with a semantics-based algorithm. Europe’s Journal of Psychology, 12(2), 210–220. https://doi.org/10.5964/ejop.v12i2.1127.
Bickel, P., Dittrich, A., & Schoepf, J. (1976). Altered states of consciousness induced by N,N-dimethyltryptamine (DMT). Pharmakopsychiatr Neuropsychopharmakol, 9(5), 220–225. https://doi.org/10.1055/s-0028-1094495. (Eine experimentelle Untersuchung zur bewusstseinsverandernden Wirkung von N,N-Dimethyltryptamin (DMT)).
Bouso, J. C., Doblin, R., Farre, M., Alcazar, M. A., & Gomez-Jarabo, G. (2008). MDMA-assisted psychotherapy using low doses in a small sample of women with chronic posttraumatic stress disorder. Journal of Psychoactive Drugs, 40(3), 225–236. https://doi.org/10.1080/02791072.2008.10400637.
Bouso, J. C., Gonzalez, D., Fondevila, S., Cutchet, M., Fernandez, X., Ribeiro Barbosa, P. C., Alcazar-Corcoles, M. A., Araujo, W. S., Barbanoj, M. J., Fabregas, J. M., & Riba, J. (2012). Personality, psychopathology, life attitudes and neuropsychological performance among ritual users of ayahuasca: A longitudinal study. PLoS One, 7(8), e42421. https://doi.org/10.1371/journal.pone.0042421.
Carhart-Harris, R. L., Erritzoe, D., Williams, T., Stone, J. M., Reed, L. J., Colasanti, A., Tyacke, R. J., Leech, R., Malizia, A. L., Murphy, K., Hobden, P., Evans, J., Feilding, A., Wise, R. G., & Nutt, D. J. (2012). Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin. Proceedings of the National Academy of Sciences of the United States of America, 109(6), 2138–2143. https://doi.org/10.1073/pnas.1119598109.
Carhart-Harris, R. L., Leech, R., Hellyer, P. J., Shanahan, M., Feilding, A., Tagliazucchi, E., Chialvo, D. R., & Nutt, D. (2014a). The entropic brain: A theory of conscious states informed by neuroimaging research with psychedelic drugs. Frontiers in Human Neuroscience, 8, 20.
Carhart-Harris, R. L., Leech, R., & Tagliazucchi, E. (2014b). How do hallucinogens work on the brain? Journal of Psychophysiology, 71(1), 2–8.
Carhart-Harris, R. L., Bolstridge, M., Day, C. M. J., Rucker, J., Watts, R., Erritzoe, D. E., Kaelen, M., Giribaldi, B., Bloomfield, M., Pilling, S., Rickard, J. A., Forbes, B., Feilding, A., Taylor, D., Curran, H. V., & Nutt, D. J. (2017). Psilocybin with psychological support for treatment-resistant depression: Six-month follow-up. Psychopharmacology. https://doi.org/10.1007/s00213-017-4771-x.
Chamberlain, S. R., Fineberg, N. A., Blackwell, A. D., Robbins, T. W., & Sahakian, B. J. (2006). Motor inhibition and cognitive flexibility in obsessive-compulsive disorder and trichotillomania. The American Journal of Psychiatry, 163(7), 1282–1284. https://doi.org/10.1176/appi.ajp.163.7.1282.
Chambers, R., Gullone, E., & Allen, N. B. (2009). Mindful emotion regulation: An integrative review. Clinical Psychology Review, 29(6), 560–572. https://doi.org/10.1016/j.cpr.2009.06.005.
Charuvastra, A., & Cloitre, M. (2008). Social bonds and posttraumatic stress disorder. Annual Review of Psychology, 59, 301–328. https://doi.org/10.1146/annurev.psych.58.110405.085650.
Cole, P. M., Michel, M. K., & Teti, L. O. D. (1994). The development of emotion regulation and dysregulation: A clinical perspective. Monographs of the Society for Research in Child Development, 59(2–3), 73–102.
Cusi, A. M., Macqueen, G. M., Spreng, R. N., & McKinnon, M. C. (2011). Altered empathic responding in major depressive disorder: Relation to symptom severity, illness burden, and psychosocial outcome. Psychiatry Research, 188(2), 231–236. https://doi.org/10.1016/j.psychres.2011.04.013.
Da Silveira, D. X., Grob, C. S., de Rios, M. D., Lopez, E., Alonso, L. K., Tacla, C., & Doering-Silveira, E. (2005). Ayahuasca in adolescence: A preliminary psychiatric assessment. Journal of Psychoactive Drugs, 37(2), 129–133. https://doi.org/10.1080/02791072.2005.10399792.
Dajani, D. R., & Uddin, L. Q. (2015). Demystifying cognitive flexibility: Implications for clinical and developmental neuroscience. Trends in Neurosciences, 38(9), 571–578. https://doi.org/10.1016/j.tins.2015.07.003.
Davis, M. H. (1983). Measuring individual differences in empathy: Evidence for a multidimensional approach. Journal of Personality and Social Psychology, 44(1), 113–126. https://doi.org/10.1037/0022-3514.44.1.113.
Davis, M. A. (2009). Understanding the relationship between mood and creativity: A meta-analysis. Organizational Behavior and Human Decision Processes, 108(1), 25–38. https://doi.org/10.1016/j.obhdp.2008.04.001.
Decety, J. (2011). Dissecting the neural mechanisms mediating empathy. Emotion Review, 3(1), 92–108.
Dobkin de Rios, M., & Rumrrill, R. (2009). A hallucinogenic tea, laced with controversy. Ayahuasca in the Amazon and the United States. Journal of Travel Medicine, 16(4), 298–298. https://doi.org/10.1111/j.1708-8305.2009.00325.x.
Doering-Silveira, E., Grob, C. S., de Rios, M. D., Lopez, E., Alonso, L. K., Tacla, C., & Da Silveira, D. X. (2005). Report on psychoactive drug use among adolescents using ayahuasca within a religious context. Journal of Psychoactive Drugs, 37(2), 141–144. https://doi.org/10.1080/02791072.2005.10399794.
Dolder, P. C., Schmid, Y., Müller, F., Borgwardt, S., & Liechti, M. E. (2016). LSD acutely impairs fear recognition and enhances emotional empathy and sociality. Neuropsychopharmacology, 41, 2638. https://doi.org/10.1038/npp.2016.82. https://www.nature.com/articles/npp201682#supplementary-information.
Dominguez-Clave, E., Soler, J., Elices, M., Pascual, J. C., Alvarez, E., de la Fuente Revenga, M., Friedlander, P., Feilding, A., & Riba, J. (2016). Ayahuasca: Pharmacology, neuroscience and therapeutic potential. Brain Research Bulletin, 126(Pt 1), 89–101. https://doi.org/10.1016/j.brainresbull.2016.03.002.
Domínguez-Clavé, E., Soler, J., Pascual, J. C., Elices, M., Franquesa, A., Valle, M., Alvarez, E., & Riba, J. (2019). Ayahuasca improves emotion dysregulation in a community sample and in individuals with borderline-like traits. Psychopharmacology, 236(2), 573–580.
Dominguez-Clavé, E., Elices, M., Morales Garcia, J. A., Pascual, J. C., Soler, J., Pérez-Castillo, A., & Riba, J. (2021). Ayahuasca as an unusually versatile therapeutic agent: From molecules to meta-cognition and back. In B. C. Labate & C. Cavnar (Eds.), Ayahuasca healing and science. in this volume.
Donges, U. S., Kersting, A., Dannlowski, U., Lalee-Mentzel, J., Arolt, V., & Suslow, T. (2005). Reduced awareness of others’ emotions in unipolar depressed patients. The Journal of Nervous and Mental Disease, 193(5), 331–337.
Dos Santos, R. G., Osorio, F. L., Crippa, J. A., & Hallak, J. E. (2016a). Antidepressive and anxiolytic effects of ayahuasca: A systematic literature review of animal and human studies. Revista Brasileira de Psiquiatria, 38(1), 65–72. https://doi.org/10.1590/1516-4446-2015-1701.
Dos Santos, R. G., Osório, F. L., Crippa, J. A. S., Riba, J., Zuardi, A. W., & Hallak, J. E. C. (2016b). Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): A systematic review of clinical trials published in the last 25 years. Therapeutic Advances in Psychopharmacology, 6(3), 193–213. https://doi.org/10.1177/2045125316638008.
Dziobek, I., Rogers, K., Fleck, S., Bahnemann, M., Heekeren, H. R., Wolf, O. T., & Convit, A. (2008). Dissociation of cognitive and emotional empathy in adults with Asperger syndrome using the Multifaceted Empathy Test (MET) [journal article]. Journal of Autism and Developmental Disorders, 38(3), 464–473. https://doi.org/10.1007/s10803-007-0486-x.
Fantegrossi, W. E., Murnane, K. S., & Reissig, C. J. (2008). The behavioral pharmacology of hallucinogens. Biochemical Pharmacology, 75(1), 17–33. https://doi.org/10.1016/j.bcp.2007.07.018.
Farb, N. A. S., Anderson, A. K., & Segal, Z. V. (2012). The mindful brain and emotion regulation in mood disorders. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie, 57(2), 70–77. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3303604/.
Forgeard, M. J. C., & Elstein, J. G. (2014). Advancing the clinical science of creativity. Frontiers in Psychology, 5, 613. https://doi.org/10.3389/fpsyg.2014.00613.
Franquesa, A., Sainz-Cort, A., Gandy, S., Soler, J., Alcázar-Córcoles, M. Á., & Bouso, J. C. (2018). Psychological variables implied in the therapeutic effect of ayahuasca: A contextual approach. Psychiatry Research, 264, 334–339.
Frecska, E., More, C. E., Vargha, A., & Luna, L. E. (2012). Enhancement of creative expression and entoptic phenomena as after-effects of repeated ayahuasca ceremonies. Journal of Psychoactive Drugs, 44(3), 191–199. https://doi.org/10.1080/02791072.2012.703099.
Frecska, E., Bokor, P., & Winkelman, M. (2016). The therapeutic potentials of ayahuasca: Possible effects against various diseases of civilization. Frontiers in Pharmacology, 7. https://doi.org/10.3389/fphar.2016.00035.
Goldin, P. R., McRae, K., Ramel, W., & Gross, J. J. (2008). The neural bases of emotion regulation: Reappraisal and suppression of negative emotion. Biological Psychiatry, 63(6), 577–586.
Grattan, L. M., & Eslinger, P. J. (1989). Higher cognition and social behavior: Changes in cognitive flexibility and empathy after cerebral lesions. Neuropsychology, 3(3), 175–185. https://doi.org/10.1037/h0091764.
Gratz, K. L., & Roemer, L. (2004). Multidimensional assessment of emotion regulation and dysregulation: Development, factor structure, and initial validation of the difficulties in emotion regulation scale. Journal of Psychopathology and Behavioral Assessment, 26(1), 41–54.
Griffiths, R. R., Richards, W. A., McCann, U., & Jesse, R. (2006). Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. Psychopharmacology, 187(3), 268–283; discussion 284–292. https://doi.org/10.1007/s00213-006-0457-5.
Grob, C. S., McKenna, D. J., Callaway, J. C., Brito, G. S., Neves, E. S., Oberlaender, G., Saide, O. L., Labigalini, E., Tacla, C., Miranda, C. T., Strassman, R. J., & Boone, K. B. (1996). Human psychopharmacology of hoasca, a plant hallucinogen used in ritual context in Brazil. The Journal of Nervous and Mental Disease, 184(2), 86–94.
Gross, J. J. (1998). The emerging field of emotion regulation: An integrative review. Review of General Psychology, 2(3), 271–299.
Gross, J. J., & Muñoz, R. F. (1995). Emotion regulation and mental health. Clinical Psychology: Science and Practice, 2(2), 151–164.
Gyurak, A., Gross, J. J., & Etkin, A. (2011). Explicit and implicit emotion regulation: A dual-process framework. Cognition & Emotion, 25(3), 400–412. https://doi.org/10.1080/02699931.2010.544160.
Harman, W. W., McKim, R. H., Mogar, R. E., Fadiman, J., & Stolaroff, M. J. (1966). Psychedelic agents in creative problem-solving: A pilot study. Psychological Reports, 19(1), 211–227.
Hasler, F., Grimberg, U., Benz, M. A., Huber, T., & Vollenweider, F. X. (2004). Acute psychological and physiological effects of psilocybin in healthy humans: A double-blind, placebo-controlled dose-effect study. Psychopharmacology, 172(2), 145–156. https://doi.org/10.1007/s00213-003-1640-6.
Hayes, A. M., & Feldman, G. (2004). Clarifying the construct of mindfulness in the context of emotion regulation and the process of change in therapy. Clinical Psychology: Science and Practice, 11(3), 255–262. https://doi.org/10.1093/clipsy.bph080.
Hendricks, P. S., Thorne, C. B., Clark, C. B., Coombs, D. W., & Johnson, M. W. (2015). Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population. Journal of Psychopharmacology, 29(3), 280–288. https://doi.org/10.1177/0269881114565653.
Hysek, C. M., Simmler, L. D., Schillinger, N., Meyer, N., Schmid, Y., Donzelli, M., Grouzmann, E., & Liechti, M. E. (2014). Pharmacokinetic and pharmacodynamic effects of methylphenidate and MDMA administered alone or in combination. The International Journal of Neuropsychopharmacology, 17(3), 371–381. https://doi.org/10.1017/s1461145713001132.
Iszáj, F., Griffiths, M. D., & Demetrovics, Z. (2017). Creativity and psychoactive substance use: A systematic review. International Journal of Mental Health and Addiction, 15(5), 1135–1149. https://doi.org/10.1007/s11469-016-9709-8.
Joormann, J., & Gotlib, I. H. (2010). Emotion regulation in depression: Relation to cognitive inhibition. Cognition and Emotion, 24(2), 281–298.
Kemmis, L., Hall, J. K., Kingston, R., & Morgan, M. J. (2007). Impaired fear recognition in regular recreational cocaine users [journal article]. Psychopharmacology (Berl), 194(2), 151–159. https://doi.org/10.1007/s00213-007-0829-5.
Kjellgren, A., Eriksson, A., & Norlander, T. (2009). Experiences of encounters with ayahuasca “the vine of the soul”. Journal of Psychoactive Drugs, 41(4), 309–315. https://doi.org/10.1080/02791072.2009.10399767.
Krippner, S. (1968). The psychedelic state, the hypnotic trance, and the creative act. Journal of Humanistic Psychology, 8(1), 49–67.
Kuypers, K. P. C., de la Torre, R., Farre, M., Yubero-Lahoz, S., Dziobek, I., Van den Bos, W., & Ramaekers, J. G. (2014). No evidence that MDMA-induced enhancement of emotional empathy is related to peripheral oxytocin levels or 5-HT1a receptor activation. PLoS One, 9(6), e100719. https://doi.org/10.1371/journal.pone.0100719.
Kuypers, K. P. C., Riba, J., de la Fuente Revenga, M., Barker, S., Theunissen, E. L., & Ramaekers, J. G. (2016). Ayahuasca enhances creative divergent thinking while decreasing conventional convergent thinking. Psychopharmacology (Berl), 233(18), 3395–3403. https://doi.org/10.1007/s00213-016-4377-8.
Kuypers, K. P. C., Dolder, P. C., Ramaekers, J. G., & Liechti, M. E. (2017). Multifaceted empathy of healthy volunteers after single doses of MDMA: A pooled sample of placebo-controlled studies. Journal of Psychopharmacology, 31(5), 589–598. https://doi.org/10.1177/0269881117699617.
Lafrance, A., Loizaga-Velder, A., Fletcher, J., Renelli, M., Files, N., & Tupper, K. W. (2017). Nourishing the spirit: Exploratory research on ayahuasca experiences along the continuum of recovery from eating disorders. Journal of Psychoactive Drugs, 49(5), 427–435.
Lawn, W., Hallak, J. E., Crippa, J. A., Dos Santos, R., Porffy, L., Barratt, M. J., Ferris, J. A., Winstock, A. R., & Morgan, C. J. A. (2017). Well-being, problematic alcohol consumption and acute subjective drug effects in past-year ayahuasca users: A large, international, self-selecting online survey. Scientific Reports, 7(1), 15201. https://doi.org/10.1038/s41598-017-14700-6.
Leary, T., Litwin, G. H., & Metzner, R. (1963). Reactions to psilocybin administered in a supportive environment. The Journal of Nervous and Mental Disease, 137, 561–573.
Luna, L. E. (2011). Indigenous and mestizo use of ayahuasca. An overview. In R. G. Santos (Ed.), The ethnopharmacology of ayahuasca (pp. 1–19). Trivandrum: Transworld Research Network.
Mason, N. L., Mischler, E., Uthaug, M. V., & Kuypers, K. P. (2019). Sub-acute effects of psilocybin on empathy, creative thinking, and subjective well-being. Journal of Psychoactive Drugs, 51(2), 123–134.
McKenna, D. J. (2004). Clinical investigations of the therapeutic potential of ayahuasca: Rationale and regulatory challenges. Pharmacology & Therapeutics, 102(2), 111–129. https://doi.org/10.1016/j.pharmthera.2004.03.002.
McKenna, D. J., Towers, G. H., & Abbott, F. (1984). Monoamine oxidase inhibitors in South American hallucinogenic plants: Tryptamine and beta-carboline constituents of ayahuasca. Journal of Ethnopharmacology, 10(2), 195–223.
McRae, K., Ochsner, K. N., Mauss, I. B., Gabrieli, J. J., & Gross, J. J. (2008). Gender differences in emotion regulation: An fMRI study of cognitive reappraisal. Group Processes & Intergroup Relations, 11(2), 143–162.
Narby, J., & Huxley, F. (2004). Shamans through time. New York City: Penguin.
Nietlisbach, G., Maercker, A., Rossler, W., & Haker, H. (2010). Are empathic abilities impaired in posttraumatic stress disorder? Psychological Reports, 106(3), 832–844. https://doi.org/10.2466/pr0.106.3.832-844.
Nunes, A. A., dos Santos, R. G., Osório, F. L., Sanches, R. F., Crippa, J. A. S., & Hallak, J. E. (2016). Effects of ayahuasca and its alkaloids on drug dependence: A systematic literature review of quantitative studies in animals and humans. Journal of Psychoactive Drugs, 48(3), 195–205.
Nutt, D. J. (2012). Drugs – without the hot air: Minimising the harms of legal and illegal drugs. Cambridge: UIT Cambridge.
Ochsner, K. N., Silvers, J. A., & Buhle, J. T. (2012). Functional imaging studies of emotion regulation: A synthetic review and evolving model of the cognitive control of emotion. Annals of the New York Academy of Sciences, 1251, E1.
Oehen, P., Traber, R., Widmer, V., & Schnyder, U. (2013). A randomized, controlled pilot study of MDMA (+/− 3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic post-traumatic stress disorder (PTSD). Journal of Psychopharmacology, 27(1), 40–52. https://doi.org/10.1177/0269881112464827.
Osorio, F. L., Sanches, R. F., Macedo, L. R., Santos, R. G., Maia-de-Oliveira, J. P., Wichert-Ana, L., Araujo, D. B., Riba, J., Crippa, J. A., & Hallak, J. E. (2015). Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: A preliminary report. Revista Brasileira de Psiquiatria, 37(1), 13–20. https://doi.org/10.1590/1516-4446-2014-1496.
Palhano-Fontes, F., Andrade, K. C., Tofoli, L. F., Santos, A. C., Crippa, J. A., Hallak, J. E., Ribeiro, S., & de Araujo, D. B. (2015). The psychedelic state induced by ayahuasca modulates the activity and connectivity of the default mode network. PLoS One, 10(2), e0118143. https://doi.org/10.1371/journal.pone.0118143.
Palhano-Fontes, F., Onias, H., Novaes, M., Andrade, K. C., Arcoverde, E., Maia-de-Oliveira, J. P., & de Araújo, D. B. (2017). Emotion processing and the antidepressant effects of ayahuasca in treatment-resistant depression: An fMRI study. Os efeitos antidepressivos da ayahuasca, suas bases neurais e relação com a experiência psicodélica, 94.
Palhano-Fontes, F., Barreto, D., Onias, H., Andrade, K. C., Novaes, M. M., Pessoa, J. A., Mota-Rolim, S. A., Osorio, F. L., Sanches, R., Dos Santos, R. G., Tofoli, L. F., de Oliveira Silveira, G., Yonamine, M., Riba, J., Santos, F. R., Silva-Junior, A. A., Alchieri, J. C., Galvao-Coelho, N. L., Lobao-Soares, B., Hallak, J. E. C., Arcoverde, E., Maia-de-Oliveira, J. P., & Araujo, D. B. (2019). Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: A randomized placebo-controlled trial. Psychological Medicine, 49(4), 655–663. https://doi.org/10.1017/s0033291718001356.
Palhano-Fontes, F., Mota-Rolim, S. A., Lobao-Soares, B., Galvao-Coelho, N. L., Maia-de-Oliveira, J. P., & Araujo, D. B. (2021). New evidence of the antidepressant effects of ayahuasca. In B. C. Labate & C. Cavnar (Eds.), Ayahuasca healing and science, in this volume.
Parlar, M., Frewen, P., Nazarov, A., Oremus, C., MacQueen, G., Lanius, R., & McKinnon, M. C. (2014). Alterations in empathic responding among women with posttraumatic stress disorder associated with childhood trauma. Brain and Behavior: A Cognitive Neuroscience Perspective, 4(3), 381–389. https://doi.org/10.1002/brb3.215.
Pokorny, T., Preller, K. H., Kometer, M., Dziobek, I., & Vollenweider, F. X. (2017). Effect of psilocybin on empathy and moral decision-making. International Journal of Neuropsychopharmacology, 20(9), 747–757. https://doi.org/10.1093/ijnp/pyx047.
Preller, K., Pokorny, T., Krähenmann, R., Dziobek, I., Stämpfli, P., & Vollenweider, F. (2015). The effect of 5-HT2A/1a agonist treatment on social cognition, empathy, and social decision-making. European Psychiatry, 30, 22.
Prochazkova, L., Lippelt, D. P., Colzato, L. S., Kuchar, M., Sjoerds, Z., & Hommel, B. (2018). Exploring the effect of microdosing psychedelics on creativity in an open-label natural setting. Psychopharmacology, 235(12), 3401–3413.
Riba, J., Rodriguez-Fornells, A., Urbano, G., Morte, A., Antonijoan, R., Montero, M., Callaway, J. C., & Barbanoj, M. J. (2001). Subjective effects and tolerability of the south American psychoactive beverage ayahuasca in healthy volunteers. Psychopharmacology, 154(1), 85–95.
Riba, J., Valle, M., Urbano, G., Yritia, M., Morte, A., & Barbanoj, M. J. (2003). Human pharmacology of ayahuasca: Subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics. The Journal of Pharmacology and Experimental Therapeutics, 306(1), 73–83. https://doi.org/10.1124/jpet.103.049882.
Riba, J., Romero, S., Grasa, E., Mena, E., Carrio, I., & Barbanoj, M. J. (2006). Increased frontal and paralimbic activation following ayahuasca, the pan-Amazonian inebriant. Psychopharmacology, 186(1), 93–98. https://doi.org/10.1007/s00213-006-0358-7.
Roemer, L., Williston, S. K., & Rollins, L. G. (2015). Mindfulness and emotion regulation. Current Opinion in Psychology, 3, 52–57.
Runco, M. A., & Acar, S. (2012). Divergent thinking as an indicator of creative potential. Creativity Research Journal, 24(1), 66–75. https://doi.org/10.1080/10400419.2012.652929.
Sampedro, F., de la Fuente Revenga, M., Valle, M., Roberto, N., Domínguez-Clavé, E., Elices, M., Luna, L. E., Crippa, J. A. S., Hallak, J. E., & de Araujo, D. B. (2017). Assessing the psychedelic “after-glow” in ayahuasca users: Post-acute neurometabolic and functional connectivity changes are associated with enhanced mindfulness capacities. International Journal of Neuropsychopharmacology, 20(9), 698–711. https://doi.org/10.1093/ijnp/pyx036.
Sanches, R. F., de Lima Osorio, F., Dos Santos, R. G., Macedo, L. R., Maia-de-Oliveira, J. P., Wichert-Ana, L., de Araujo, D. B., Riba, J., Crippa, J. A., & Hallak, J. E. (2016). Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: A SPECT study. Journal of Clinical Psychopharmacology, 36(1), 77–81. https://doi.org/10.1097/jcp.0000000000000436.
Santos, R. G., Landeira-Fernandez, J., Strassman, R. J., Motta, V., & Cruz, A. P. (2007). Effects of ayahuasca on psychometric measures of anxiety, panic-like and hopelessness in Santo Daime members. Journal of Ethnopharmacology, 112(3), 507–513. https://doi.org/10.1016/j.jep.2007.04.012.
Schipper, M., & Petermann, F. (2013). Relating empathy and emotion regulation: Do deficits in empathy trigger emotion dysregulation? Social Neuroscience, 8(1), 101–107. https://doi.org/10.1080/17470919.2012.761650.
Schmid, Y., Hysek, C. M., Simmler, L. D., Crockett, M. J., Quednow, B. B., & Liechti, M. E. (2014). Differential effects of MDMA and methylphenidate on social cognition. Journal of Psychopharmacology, 28(9), 847–856. https://doi.org/10.1177/0269881114542454.
Schultes, R. G., & Hofmann, A. (1979). Plants of the gods: Origins of hallucinogenic use. New York: McGraw-Hill.
Sessa, B. (2008). Is it time to revisit the role of psychedelic drugs in enhancing human creativity? Journal of Psychopharmacology, 22(8), 821–827. https://doi.org/10.1177/0269881108091597.
Shanon, B. (2000). Ayahuasca and creativity. MAPS Newsletter, 10(3), 18–19. https://maps.org/news-letters/v10n3/10318sha.pdf.
Shewan, D., Dalgarno, P., & Reith, G. (2000). Perceived risk and risk reduction among ecstasy users: The role of drug, set, and setting. International Journal of Drug Policy, 10(6), 431–453.
Sloan, D. M. (2004). Emotion regulation in action: Emotional reactivity in experiential avoidance. Behaviour Research and Therapy, 42(11), 1257–1270. https://doi.org/10.1016/j.brat.2003.08.006.
Smith, R. L., Canton, H., Barrett, R. J., & Sanders-Bush, E. (1998). Agonist properties of N,N-dimethyltryptamine at serotonin 5-HT2A and 5-HT2C receptors. Pharmacology, Biochemistry, and Behavior, 61(3), 323–330.
Soler, J., Elices, M., Franquesa, A., Barker, S., Friedlander, P., Feilding, A., Pascual, J. C., & Riba, J. (2016). Exploring the therapeutic potential of ayahuasca: Acute intake increases mindfulness-related capacities. Psychopharmacology (Berl), 233(5), 823–829. https://doi.org/10.1007/s00213-015-4162-0.
Tagliazucchi, E., Carhart-Harris, R. L., Leech, R., Nutt, D., & Chialvo, D. R. (2014). Enhanced repertoire of brain dynamical states during the psychedelic experience. Human Brain Mapping, 35(11), 5442–5456. https://doi.org/10.1002/hbm.22562.
Thomas, G., Lucas, P., Capler, N. R., Tupper, K. W., & Martin, G. (2013). Ayahuasca-assisted therapy for addiction: Results from a preliminary observational study in Canada. Current Drug Abuse Reviews, 6(1), 30–42.
Todd, A. R., Forstmann, M., Burgmer, P., Brooks, A. W., & Galinsky, A. D. (2015). Anxious and egocentric: How specific emotions influence perspective taking. Journal of Experimental Psychology. General, 144(2), 374–391. https://doi.org/10.1037/xge0000048.
Tull, M. T., Barrett, H. M., McMillan, E. S., & Roemer, L. (2007). A preliminary investigation of the relationship between emotion regulation difficulties and posttraumatic stress symptoms. Behavior Therapy, 38(3), 303–313. https://doi.org/10.1016/j.beth.2006.10.001.
Tupper, K. W. (2009). Ayahuasca healing beyond the Amazon: The globalization of a traditional indigenous entheogenic practice. Global Networks, 9(1), 117–136. https://doi.org/10.1111/j.1471-0374.2009.00245.x.
Uthaug, M. V., van Oorsouw, K., Kuypers, K. P. C., van Boxtel, M., Broers, N. J., Mason, N. L., Toennes, S. W., Riba, J., & Ramaekers, J. G. (2018). Sub-acute and long-term effects of ayahuasca on affect and cognitive thinking style and their association with ego dissolution. Psychopharmacology, 235(10): 2979–2989.
Uthaug, M. V., Lancelotta, R., van Oorsouw, K., Kuypers, K., Mason, N., Rak, J., Šuláková, A., Jurok, R., Maryška, M., & Kuchař, M. (2019). A single inhalation of vapor from dried toad secretion containing 5-methoxy-N, N-dimethyltryptamine (5-MeO-DMT) in a naturalistic setting is related to sustained enhancement of satisfaction with life, mindfulness-related capacities, and a decrement of psychopathological symptoms. Psychopharmacology (Berl), 236(9):2653–2666.
Visted, E., Sørensen, L., Osnes, B., Svendsen, J. L., Binder, P.-E., & Schanche, E. (2017). The association between self-reported difficulties in emotion regulation and heart rate variability: The salient role of not accepting negative emotions. Frontiers in Psychology, 8, 328. https://doi.org/10.3389/fpsyg.2017.00328.
Vollenweider, F. X., & Kometer, M. (2010). The neurobiology of psychedelic drugs: Implications for the treatment of mood disorders. Nature Reviews. Neuroscience, 11(9), 642–651. https://doi.org/10.1038/nrn2884.
Williams, D. P., Cash, C., Rankin, C., Bernardi, A., Koenig, J., & Thayer, J. F. (2015). Resting heart rate variability predicts self-reported difficulties in emotion regulation: A focus on different facets of emotion regulation. Frontiers in Psychology, 6, 261. https://doi.org/10.3389/fpsyg.2015.00261.
Winkelman, M. (2005). Drug tourism or spiritual healing? Ayahuasca seekers in Amazonia. Journal of Psychoactive Drugs, 37(2), 209–218. https://doi.org/10.1080/02791072.2005.10399803.
Zeifman, R., Palhano-Fontes, F., Hallak, J., Nunes, E. A., Maia-de-Oliveira, J. P., & de Araujo, D. B. (2019). The impact of ayahuasca on suicidality: Results from a randomized controlled trial. Frontiers in Pharmacology, 10, 1325.
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Mason, N.L., Kuypers, K.P.C. (2021). Acute and Long-Term Effects of Ayahuasca on (Higher-Order) Cognitive Processes. In: Labate, B.C., Cavnar, C. (eds) Ayahuasca Healing and Science. Springer, Cham. https://doi.org/10.1007/978-3-030-55688-4_7
Download citation
DOI: https://doi.org/10.1007/978-3-030-55688-4_7
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-55687-7
Online ISBN: 978-3-030-55688-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)